Literature DB >> 9776363

Catecholamine transport by the organic cation transporter type 1 (OCT1).

T Breidert1, F Spitzenberger, D Gründemann, E Schömig.   

Abstract

1. Liver and kidney extract adrenaline and noradrenaline from the circulation by a mechanism which does not seem to be one of the classical catecholamine transporters. The hypothesis that OCT1 is involved the organic cation transporter type 1 which exists in rat kidney and liver-was tested. 2. Based on human embryonic kidney cells (293), we constructed a cell line which stably expresses OCT1r (293OCT1r cells). Transfection with OCT1 resulted in a transport activity not only for prototypical known substrates of OCT1 such as 3H-1-methyl-4-phenylpyridinium and 14C-tetraethylammonium but also for the catecholamines 3H-adrenaline, 3H-noradrenaline (3H-NA) and 3H-dopamine (3H-DA), the indoleamine 3H-5-hydroxytryptamine (3H-5HT) as well as the indirect sympathomimetic 14C-tyramine. 3. For 3H-DA, 3H-5HT and 3H-NA, at non-saturating concentrations, the rate constants for inwardly directed substrate flux (kin) were 6.9+/-0.8, 3.1+/-0.2, and 1.2+/-0.1 microl min(-1) mg protein(-1). In wild type cells (293WT) the corresponding kin's were considerably lower, being 0.94+/-0.40, 0.47+/-0.08 and 0.23+/-0.05 microl min(-1) mg protein ' (n=12). The indirectly determined half-saturating concentrations of DA, 5HT, and NA were 1.1 (95% c.i.: 0.8, 1.4), 0.65 (0.49, 0.86), and 2.8 (2.1, 3.7) mmol l(-1) (n=3). 4. Specific 3H-DA uptake in 293OCT1r cells was resistant to cocaine (1 micromoll(-1)), 3H-5HT uptake was resistant to citalopram (300 nmol l(-1)) and 3H-NA uptake was resistant to desipramine (100 nmoll(-1)), corticosterone (1 micromol l(-1)), and reserpine (10 nmoll(-1)) which rules out the involvement of classical transporters for biogenic amines. 5. The findings demonstrate that OCTI efficiently transports catecholamines and other biogenic amines and support the hypothesis that OCT1 is responsible for hepatic and renal inactivation of circulating catecholamines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776363      PMCID: PMC1565608          DOI: 10.1038/sj.bjp.0702065

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters.

Authors:  I Wessler; E Roth; C Deutsch; P Brockerhoff; F Bittinger; C J Kirkpatrick; H Kilbinger
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.

Authors:  Kelli H Boxberger; Bruno Hagenbuch; Jed N Lampe
Journal:  Drug Metab Dispos       Date:  2014-03-31       Impact factor: 3.922

3.  Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells.

Authors:  Dirk Gründemann; Ann-Cathrin Koschker; Christine Haag; Cornelius Honold; Tim Zimmermann; Edgar Schömig
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene.

Authors:  J W Jonker; E Wagenaar; C A Mol; M Buitelaar; H Koepsell; J W Smit; A H Schinkel
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Are organic cation transporters capable of transporting prostaglandins?

Authors:  Stephanie Harlfinger; Christian Fork; Andreas Lazar; Edgar Schömig; Dirk Gründemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-07       Impact factor: 3.000

6.  Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice.

Authors:  R Zwart; S Verhaagh; M Buitelaar; C Popp-Snijders; D P Barlow
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.

Authors:  Hai T Nguyen; Bruno P Guiard; Alexandre Bacq; Denis J David; Indira David; Gaël Quesseveur; Sophie Gautron; Connie Sanchez; Alain M Gardier
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

8.  Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.

Authors:  Johan W Jonker; Els Wagenaar; Sven Van Eijl; Alfred H Schinkel
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 9.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

10.  OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users.

Authors:  Matthijs L Becker; Loes E Visser; Ron H N van Schaik; Albert Hofman; André G Uitterlinden; Bruno H Ch Stricker
Journal:  Neurogenetics       Date:  2010-08-01       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.